Faculty

Bio

I am a child psychologist with an interest in adolescent depression and psychotherapy at the Department of Psychiatry & Behavioral Sciences. I received my BA in psychology from the University of Wisconsin in Eau-Claire, graduating summa cum laude. I received my MA in counseling psychology from Bethel University in St. Paul, MN. I completed my PsyD in counseling psychology at the University of St. Thomas in Minneapolis, MN, and then completed a postdoctoral fellowship in clinical psychology and research in the Child and Adolescent Mood and Anxiety Disorders Program here at the University of Minnesota.

I provide clinical services to children, adolescents, and adults. I also provide psychotherapy to parents with their own mental health concerns and parents of children experiencing mental illness. I am trained in Interpersonal Psychotherapy for depressed adolescents (IPT-A) and Cognitive Behavioral Therapy (CBT), including Exposure and Response Prevention. 

My research interests include developing and implementing effective treatments for adolescent depression, maternal mental health, and promoting positive parenting practices. I am a co-investigator for the RADLab (Research in Adolescent Depression), which aims to advance understanding of the biology of mood disorders in adolescents and to test how investigational treatments may work to restore health in young people.

Within the University of Minnesota Medical School, I provide training and supervision for clinical psychology graduate students and psychiatry residents and fellows.

Expertise

• Psychotherapy
• Parent-based interventions to address disruptions in parent-adolescent attachment
• Adolescent psychopathology
• Parental mental health

Administrative Assistant

(for academic support only)
Molly Jokimaki
jokim004@umn.edu

In the Media

• 2022: Coauthor of a study featured (although not named) in this MIDB article: "First Study to Evaluate Neurobiological Predictors of Interpersonal Psychotherapy for Depressed Adolescents".

Research Summary

Dr. Reigstad's research interests include the development and implementation of evidence-based interventions for adolescent depression, maternal mental health and maternal depression, and positive parenting practices. Dr. Registad's research is focused on the interpersonal processes implicated in the link between parental depression and child and adolescent depression, and associations between improvement in parents' depression and their children's psychopathology. She also conducts research on the interpersonal context of depression, and she is interested in the impact of parent-child attachment relationships on child and parent functioning.

Teaching Summary

Dr. Reigstad provides training and supervision for clinical psychology graduate students and psychiatry residents and fellows in the University of Minnesota Medical School.

Clinical Summary

Dr. Reigstad is a Licensed Psychologist in Minnesota and provides individual psychotherapy and psychological assessments in the Child & Adolescent Anxiety and Mood Disorders Clinic. She provides clinical services to children, adolescents and adults. She provides psychotherapy to parents with their own mental health concerns and parents of children experiencing mental illness.

Dr. Reigstad is trained in Interpersonal Psychotherapy for depressed adolescents (IPT-A) and Cognitive-Behavioral (CBT), including Exposure and Response Prevention.

Bio

I am a clinical psychologist who specializes in the assessment and treatment of individuals with substance use and comorbid psychiatric disorders. In addition to individual therapy, I facilitate a weekly Relapse Prevention Group based on cognitive-behavioral principles. Within the Department, I train and supervise psychology doctoral students and psychiatry residents.

I received my BA in Liberal Studies from the University of Notre Dame, IN. I completed both my master's and PhD in clinical psychology from Duke University, NC. I further completed a postdoctoral fellowship focused on substance use disorders from Brown University/Providence VA Medical Center, RI.

My research focuses on alcohol and cannabis co-use, opioid use disorder, and psychosocial interventions for substance use disorders.

Expertise

• Mood and anxiety disorders
• Cognitive Behavioral Therapy (CBT)
• Motivational interviewing

Administrative Assistant

(for academic support only)
Natasha Hampton-Anderson
nhampton@umn.edu

In the Media

• 2021: Featured in this article titled, "5 Tips for Choosing a Psychotherapist".

Research Summary

Dr. Rinehart's research focuses on alcohol and cannabis co-use, including understanding how cannabis use impacts relapse to alcohol among patients with an alcohol use disorder. She also examines how cannabis use impacts treatment outcomes for mood, anxiety, and other drug use disorders.

Bio

Dr. Rittberg’s education includes a BS with distinction in Chemistry from the University of Wisconsin, Milwaukee; an MD from the University of Wisconsin; and a psychiatry residency at the University of Minnesota. He was elected to memberships in the Phi Beta Kappa and Alpha Omega Alpha honor societies. 

His research has been on novel antidepressants, vagus nerve stimulation for depression, deep brain stimulation for depression, and ketamine-like drugs. He has taught residents and medical students for almost 4 decades and specializes in psychopharmacology. His main area of interest is treatment-resistant depression.

Expertise

• Psychiatry and mood disorders

Research Summary

Somatic treatment of Mood Disorders Clinical trials of novel agents and Vagus Nerve Stimulation

Bio

Administrative Assistant

(for academic support only)
Teneshia Collins
coll1148@umn.edu

Bio

I received my BS in Psychology from Pennsylvania State University. I completed my master's and PhD in Psychobiology and Neuroscience from Florida State University. I further completed my postdoctoral fellowship in Behavioral Pharmacology here at the University of Minnesota. I am an Emeritus Professor of Psychology and Neuroscience and my research is focused on factors that underlie drug and food addiction, such as genetic differences, impulsivity, and hormonal influences. As Director of a recent P50 Center grant, I conduct translational research with animal and human subjects on sex differences, stimulant addiction and novel treatments. Currently, I am developing animal models of novel self-initiated and -maintained long-term treatments for addiction with the translational goal of having addicted drug users manage their treatment and recovery over long periods of time. I have over 200 publications, 11,000 citations, and an h-index of 58.I have been awarded the University of Minnesota President's and Medical School's Neuroscience Initiative Award, every year since 2005. I am active in national and local community events including Brain Awareness Week, the Winter Conference on Brain Research Community Outreach and at the Minnesota State Fair's Neuroscience booth.

Expertise

• Behavioral pharmacology and biological factors in addiction
• Environmental factors in addiction 
• Novel behaviors and pharmacological treatment for drug abuse

Research Summary

The goal of my research is to develop behavioral and pharmacological methods for reducing and preventing drug abuse. In recent work with graduate students and postdocs, we examined the influence of individual differences such as impulsivity, sweet preference, sex/hormonal factors, and genetic factors that maintain drug addiction. A current interest is to understand treatment failure in human drug addicts, as success of treatments is no higher than self-quit methods. Our hypothesis is that treatments fail because craving incubates over long periods after treatment ends. We use self-initiated, self-maintained, long-term treatments, such as physical exercise, to block incubation of craving for weeks to months. We also study another aspect of incubated craving, multiply-triggered-relapse (MTR). After several weeks of forced abstinence we found that in addition to the previously-used drug, multiple cues in the environment (e.g., other drugs of abuse, common drugs such as caffeine and nicotine, and environmental cues) trigger relapse. Incubation of craving and MTR are the targets we are currently studying for treatment development. We are testing self-initiated, long-lasting and self-maintained treatments, such as voluntary exercise and social reward that, alone and/or together, are self-motivated and self-maintained long-term self-treatments for reducing incubation of craving and MTR. We are working with clinical addiction investigators and exercise physiologists to translate these treatment strategies to humans.

Bio

I completed a B.S. in Brain, Behavior, and Cognitive Science at the University of Michigan, where I conducted an honors thesis using functional MRI to study word list learning with Dr. Scott A. Langenecker.  I completed my Ph.D. in Neuroscience at the University of Minnesota with Dr. Cheryl A. Olman. My doctoral work used functional MRI and behavioral psychophysics to examine how early visual processing (e.g., contrast perception) is affected by psychosis. Next, I worked as a post-doctoral research associate with Dr. Scott O. Murray in the Department of Psychology at the University of Washington. My work examined how low-level vision (e.g. motion perception) is affected by autism spectrum disorders, using methods such as functional MRI, MR spectroscopy, and EEG.

I am an Assistant Professor in the Department of Psychiatry & Behavioral Sciences. My research focuses on understanding how visual perception is affected by different psychiatric and neurological conditions. I am the Primary Investigator for an NIMH K01-funded study using EEG and MR spectroscopy to understand early visual perception in schizophrenia. I am also involved in a number of other projects focused on visual perception in clinical populations including psychosis spectrum disorders and visual snow syndrome. Within the department, I am Co-Chair of the Grand Rounds Committee, the Chairperson of a Junior Faculty Peer Mentorship Group, and Co-Director of the Ambulatory Research Center Psychophysiology Laboratory. 

Expertise

• Schizophrenia 

Administrative Assistant

(for academic support only)
Teneshia Collins
coll1148@umn.edu

Research Summary

Dr. Schallmo's interests include: Disrupted perception in psychosis and autism spectrum disorders (ASD) The role of different neurotransmitters (e.g., GABA, glutamate) in psychosis and ASD Visual neuroscience as a tool to examine specific hypotheses about the neural mechanisms of psychiatric disorders Combining methods (e.g., functional MRI, EEG, MR spectroscopy, visual psychophysics, pharmacology) to study a single research question in human subjects

Bio

I received my BA from the University of Chicago. I completed medical school here at the University of Minnesota. I completed my psychiatry residency in general psychiatry from the University of Iowa Hospitals and Clinics, and my fellowship in child and adolescent psychiatry from Boston Children's Hospital (Harvard Medical School), Boston, where I was Chief Fellow. I am a child and adolescent psychiatrist with a focus on consultation-liaison psychiatry, mood and anxiety disorders, and developing new clinical programs for children with coexisting physical and psychiatric illnesses. Within the department, I am a member of the Advocacy Committee.

Administrative Assistant

(for academic support only)
Shelly Slominski
slomi001@umn.edu

In the Media

• 2022: Featured in this article titled, "Interprofessional collaboration at the U aims to improve mental health treatment for children and adolescents".

Bio

I am a Clinical Psychologist on faculty in the Department of Psychiatry and Behavioral Sciences and adjunct faculty in the Department of Psychology at the University of Minnesota. My education includes a Master’s degree in cognitive psychology from the Universität Regensburg, Germany, a PhD in clinical science from Vanderbilt University, TN, and a postdoctoral fellowship at the University of Pennsylvania & the A.T. Beck Institute, PA. Prior to joining the University of Minnesota, I worked in a variety of healthcare settings including the University of Illinois - Chicago, the practice group RICBT & OneCBT, and Allina Health.

In the Department of Psychiatry and Behavioral Sciences, I direct Psychology Education, co-chair the Education Council, oversee clinical psychology training, and direct CBT training for the psychiatry residency program. My education mission centers around empirically-validated team-based patient care, interprofessional learning, and mentorship of trainees across disciplines. I also serve as a certified Crucial Conversations Trainer leading workshops on the art of holding critical conversations well.

Expertise

• Unipolar and bipolar mood disorders
• Multidisciplinary interventions for mood disorders
• Cognitive Behavioral Therapy (CBT)

Administrative Assistant

(for academic support only)
Molly Jokimaki
jokim004@umn.edu

In the Media

• 2023: Quoted in this Minnesota Daily article titled, “Fareed: The loneliness epidemic: a silent crisis.”
• 2023: Featured in this article titled, “Celebrating the many ways that psychologists help us.”
• 2023: Featured in this Minnesota Daily article titled, “Could the Sunshine Protection Act prevent the winter blues?
• 2022: Featured in this Woman’s World article titled, “Expert Advice: How Can I Feel Less Lonely During the Holidays?
• 2022: Featured in this article titled, “Treating seasonal affective disorder as winter looms.
• 2022: Quoted in this Consumer Reports article titled, "Find the Right Therapist for You".
• 2022: Featured in this Detroit Lakes Tribune article titled, "Health Fusion: Don't let SAD drive your bus". 
• 2021: Helps us get through the winter blues in this Medical School video titled, "Ask a U of M Expert: Tips for coping with SAD".
• 2021: Featured in this article titled, "5 Tips for Choosing a Psychotherapist".
• 2020: Interviewed by WCCO radio in a piece titled, Mental health experts warn that the holiday season could be "the hardest part" of the pandemic, by KSTP TV, Expert offers tips for those experiencing loneliness during the pandemic, holidays, and by Fox21, Mental Health Experts Concerned About Loneliness This Holiday Season. 

Research Summary

As a scientist-practitioner, I dedicate my career to translating scientific research into best practices in mental healthcare. My research interest is in the development and implementation of evidence-based interventions for mood disorders, specifically the integration of Cognitive Behavioral Therapy (CBT) with emerging biological interventions. Currently, I serve as site PI for a PCORI-funded empirical study comparing novel depression interventions.

Teaching Summary

I am passionate about training, teaching, and mentoring psychology graduate students, psychiatry residents, postdoctoral fellows, and junior faculty in the evaluation and evidence based team-based intervention for mood disorders and in professional development.

Clinical Summary

I am clinically licensed in Minnesota and certified in CBT by the Academy of Cognitive and Behavioral Therapies. I provide care and consultation in multidisciplinary specialty clinics for Treatment Resistant Depression (TRD) and Early-Stage Mood Disorders (ESMD). My clinical practice is rooted in scientific research and integrates CBT with modern empirically- based approaches including Behavioral Activation (BA) and Acceptance and Commitment Therapy (ACT). 

Bio

I am an Assistant Professor in the Department of Psychiatry & Behavioral Sciences, Child and Adolescent Mental Health Division, and Masonic Institute for the Developing Brain, as well as an Institute for Translational Neuroscience Scholar. I earned my PhD (Clinical Psychology) from the University of Pittsburgh, with secondary training from Carnegie Mellon University (Cognitive Neuroscience), focusing on the intersection of developmental cognitive neuroscience, mental health research, and computational methods. I trained at Massachusetts General Hospital/Harvard Medical School for my predoctoral clinical internship and postdoctoral fellowship, with an emphasis on research and treatment of adolescents with substance use disorders.

Research in my lab aims to understand normative brain development and the emergence of mental health and substance use disorders during adolescence, integrating techniques from developmental cognitive neuroscience, computational methods, and psychopathology research. We are also engaged in methodological work aiming to evaluate and improve the reproducibility and ultimately, clinical and policy utility, of large-scale fMRI and behavioral assessment research in neurodevelopmental studies.

Administrative Assistant

(for academic support only)
Shelly Slominski
slomi001@umn.edu

In the Media

• 2024: Research featured in this New York Times article, titled, “Teen Drug and Alcohol Use Linked to Mental Health Distress.”
• 2024: Featured in this Medical School article titled, “High school students who report using alcohol, cannabis or nicotine at higher risk for suicidal thoughts and other mental health disorders”
• 2023: Featured in this article titled, "Is Your 18-Year-Old Really 'Mature'? New Brain Study Has Answers".
• 2023: The focus of this article titled, “Integrating his clinical work into his research an exciting prospect for new faculty member.”
• 2022: Invited on the Flux Society [Developmental Cognitive Neuroscience]: Sensitive Periods Podcast.
• 2022: Invited on the Organization for Human Brain Mapping (OHBM) Neurosalience Podcast 
• 2022: Featured on KCBS, San Francisco. Click here for more information. 
• 2022: Research featured on Psychology Today, Click here for the article.
• 2021: Featured on WHYY, National Public Radio (NPR)-Affiliate, Philadelphia, Click here for more information.